ST Elevation Myocardial Infarction in a Patient with Hereditary Hemorrhagic Telangiectasia Involving the Liver
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
This is a case report of a 71-year-old woman with hereditary hemorrhagic telangiectasia (hereditary hemorrhagic telangiectasia [HHT], Osler–Weber–Rendu syndrome) involving the liver who developed ST elevation myocardial infarction and died from aggressive coronary thrombosis. HHT is an autosomal dominant hereditary disease associated with mutations of genes that regulate the endothelial surface. It has characteristic muco-cutaneous telangiectasia and other common manifestations are epistaxis, gastrointestinal bleeding, and iron-deficiency anemia. In addition, arteriovenous malformations or vascular ectases commonly occur in the pulmonary, hepatic, and cerebral circulations. Hemorrhages and thrombosis can both develop from these vascular abnormalities in HHT. Most thrombotic events are forms of venous thrombosis, such as deep vein thrombosis, while arterial thrombosis occurs infrequently. We present a case of aggressive coronary thrombosis in HHT, as a rare complication of HHT.
Abstract
This is a case report of a 71-year-old woman with hereditary hemorrhagic telangiectasia (hereditary hemorrhagic telangiectasia [HHT], Osler–Weber–Rendu syndrome) involving the liver who developed ST elevation myocardial infarction and died from aggressive coronary thrombosis. HHT is an autosomal dominant hereditary disease associated with mutations of genes that regulate the endothelial surface. It has characteristic muco-cutaneous telangiectasia and other common manifestations are epistaxis, gastrointestinal bleeding, and iron-deficiency anemia. In addition, arteriovenous malformations or vascular ectases commonly occur in the pulmonary, hepatic, and cerebral circulations. Hemorrhages and thrombosis can both develop from these vascular abnormalities in HHT. Most thrombotic events are forms of venous thrombosis, such as deep vein thrombosis, while arterial thrombosis occurs infrequently. We present a case of aggressive coronary thrombosis in HHT, as a rare complication of HHT.
참고문헌 (9)
- Begbie ME, "Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century", Postgrad Med J, 79, pp.18~24 (2003)
- Richards S, "Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology", Genet Med, 17, pp.405~424 (2015)
- Govani FS, "Hereditary haemorrhagic telangiectasia:a clinical and scientific review", Eur J Hum Genet, 17, pp.860~871 (2009)
- Sabbà C, "Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1mutation carriers", J Thromb Haemost, 5, pp.1149~1157 (2007)
- Garcia-Tsao G, "Liver disease in patients with hereditary hemorrhagic telangiectasia", N Engl J Med, 343, pp.931~936 (2000)
- Livesey JA, "Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli", deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia, 2012, pp.67, 328~333
- Clark K, "Angina pectoris or myocardial infarctions, pulmonary arteriovenous malformations, hereditary hemorrhagic telangiectasia, and paradoxical emboli", Am J Cardiol, 112, pp.731~734 (2013)
- Prandoni P, "Venous and arterial thrombosis: two aspects of the same disease?", Clin Epidemiol, 1, pp.1~6 (2009)
- Martinelli I, "von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis", Semin Hematol, 42, pp.49~55 (2005)